LISCure Biosciences Announces Oral Presentation of New Drug Candidate for NASH at Upcoming AASLD The Liver Meeting 2022
The efficacy and mechanism of NASH microbiome-based therapy for liver fibrosis, steatosis, and inflammation have been confirmed in various animal models SEOUL, South Korea, Oct. 28, 2022 /PRNewswire/ -- LISCure Biosciences, a clinical-stage biopharmaceutical company developing microbe-oriented new drugs based on innovative technologies, today announced that a new drug candidate for NASH was selected for an oral presentation at...
Future of Healthcare Week Asia: Building sustainable systems for all
A hybrid event unifying the public, private and civil sectors from health and technology to foster better healthcare for all and ensure continuity of care. Speakers include Budi Gunadi Sadikin, Indonesia's Minister of Health; Kai-Fu Lee, Sinovation Ventures's chairman and chief executive; Cheong Wei Yang, deputy secretary (technology) of Singapore's Ministry of Health. SINGAPORE, Oct. 28, 2022...
Hinova Disclosed the Preclinical Results of HP518 (Oral AR PROTAC) at the 5th Annual TPD Summit
BOSTON, Oct. 28, 2022 /PRNewswire/ -- Hinova Pharmaceuticals Inc. (STAR: 688302), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cancers and metabolic diseases through targeted protein degradation technologies, today presented their preclinical results of HP518, an orally bioavailable chimeric degrader targeting androgen receptor (AR) for prostate cancer treatment, at the 5th Annual TPD Summit. Discovered and...
International Experts Recommend Nuts and Dried Fruits as Part of a Healthy Diet
The International Nut and Dried Fruit Council hosted a historic meeting of global health researchers, where diabetes was defined as a key topic for investigation BARCELONA, Spain, Oct. 28, 2022 /PRNewswire/ -- From October 20-21, 2022, the world's leading researchers gathered for NUTS 2022 to discuss the current and future of health research on nuts and dried fruits. NUTS 2022...
Stamford American celebrates Global Be Well Day, highlighting the importance of well-being
Stamford American students take time during Global Be Well Day to do stretching exercises on the sports field and dance to music. SINGAPORE, Oct. 28, 2022 /PRNewswire/ -- Well-being has been one of the most important issues facing Singapore recently, and there are signs the Lion City has begun to take notice. Particularly in the education sector, well-being has proven...
Novel, Biocompatible UV Light Absorber: WPI-MANA
TSUKUBA, Japan, Oct. 28, 2022 /PRNewswire/ -- An International research team at the International Center for Materials Nanoarchitectonics (WPI-MANA) has developed a biocompatible ultraviolet (UV) light-shielding compound from naturally occurring aqueous iron(III), hereinafter aqua-Fe(III), complexes stabilized inside a layered silicate scaffold. (Image: https://kyodonewsprwire.jp/prwfile/release/M105739/202210248607/_prw_PI1fl_q4oTuUCH.jpg) UV-absorbing materials are important to many industries, spanning healthcare, cosmetics, and material protection, among others....
Pharming Announces European Medicines Agency (EMA) Validates its Marketing Authorisation Application under Accelerated Assessment for leniolisib
Marketing authorisation in the European Economic Area anticipated in H1 2023 LEIDEN, Netherlands, Oct. 28, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM / Nasdaq: PHAR) announces today that its Marketing Authorisation Application (MAA) for leniolisib has been validated for scientific evaluation under an accelerated assessment...
2022 Digitisation in Traditional Medicine World Summit successfully held in Macau
Joint discussion on digitisation with credit initiative between China and ASEAN countries MACAU, Oct. 28, 2022 /PRNewswire/ -- Here is the report from Macau business By Tony Lai: A conference about digitisation of the industry of Traditional Complementary Medicine (TCM) was held in Macau on Friday (Oct.,21,2022), facilitating innovations in the sector and strengthening the city's platform role for it. ...
Acceptance Of The Application For Clinical Trial Of Recbio Novel Adjuvanted Recombinant Quadrivalent HPV Vaccine
TAIZHOU, China, Oct. 28, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (the "Company", together with its subsidiaries, the "Group") is pleased to announce that, the Group has recently received a notice of acceptance from the National Medical Products Administration to accept the application for a clinical trial of in-housed developed novel...
Sebela Pharmaceuticals® Acquires Exclusive Licensing Rights to Develop and Commercialize Tegoprazan in the U.S. and Canada
Phase 3 Trials Initiated with Tegoprazan for the Treatment of Erosive Esophagitis and Non-erosive Reflux Disease BRAINTREE, Mass., Oct. 28, 2022 /PRNewswire/ -- Sebela Pharmaceuticals® has entered an exclusive partnership with HK inno.N Corporation to license tegoprazan in the United States and Canada. Under the agreement, Braintree Laboratories, a leader in gastroenterology and an affiliate of Sebela Pharmaceuticals, will be responsible...
